TAL-61

N/A

Report date: 2026/04/10 20:01:49
NME

Base Information

Drug NameTAL-61
Drug Alias NameTAL-61
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionT-box transcription factor T inhibitors
TargetsT-box transcription factor T
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungChordoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTalus Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesTalus Bioscience Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell LungChordoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A